LEADER 04980nam 2200589 450 001 9910140489503321 005 20230807210351.0 010 $a1-119-00623-6 010 $a1-119-00603-1 035 $a(CKB)2670000000612411 035 $a(EBL)1895901 035 $a(SSID)ssj0001459653 035 $a(PQKBManifestationID)11785348 035 $a(PQKBTitleCode)TC0001459653 035 $a(PQKBWorkID)11464794 035 $a(PQKB)10054320 035 $a(MiAaPQ)EBC4547742 035 $a(MiAaPQ)EBC1895901 035 $a(DLC) 2014050004 035 $a(Au-PeEL)EBL1895901 035 $a(CaPaEBR)ebr11048205 035 $a(OCoLC)899114025 035 $a(EXLCZ)992670000000612411 100 $a20150508h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aPhytotherapies $eefficacy, safety and regulation /$fedited by Iqbal Ramzan 210 1$aHoboken, New Jersey :$cWiley,$d2015. 210 4$dİ2015 215 $a1 online resource (683 p.) 300 $aDescription based upon print version of record. 311 $a1-119-00611-2 311 $a1-118-26806-7 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $aPhytotherapies : past, present, and future / Iqbal Ramzan, George Q. Li -- Quality control and quality assurance of phytomedicines : key considerations, methods, and analytical challenges / Wai-Ping Yau, Cheong Hian Goh, Hwee-Ling Koh -- Pre-clinical (in vivo) and laboratory (in vitro) evidence of phytomedicine efficacy / Mohi Iqbal Mohammed Abdul, Tom Hsun-Wei Huang -- Clinical efficacy trials with herbal medicines / Christina L. Nance -- Novel formulations and drug delivery systems for phytotherapies / Shengpeng Wang, Meiwan Chen, Qi (Tony) Zhou, Hak-Kim Chan -- Phytotherapies used by indigenous populations / Bradley S. Simpson, Susan J. Semple -- Phytotherapies from traditional Chinese medicines / Michael Rieder -- Integrating traditional Greco-Arab and Islamic herbal medicine in research and clinical practice / Bashar Saad -- Evolution of herbal medicine in Europe and its relationship with modern medicine / Elizabeth M Williamson, Kelvin Chan -- Chemical classification and chemistry of phytotherapeutic constituents / Pei H. Cui, Colin C. Duke -- Therapeutic potential of ginsenosides in management of atherosclerosis / Xiao-Jing Zhang, Huanxing Su, Jian-Bo Wan, Yi-Tao Wang -- Phytotherapy pharmacophores for major cellular drug targets / Jennifer A. Ong, Paul W. Groundwater, David E. Hibbs -- Use of kava as a phytotherapeutic agent and kava related hepatotoxicity / Dong Fu, Iqbal Ramzan -- Phytotherapies as new drug sources : gossypol and curcumin / Vivian Wan Yu Liao, Rajeshwar Narlawar, David E. Hibbs, Paul W. Groundwater -- Phytotherapies for the management of obesity and diabetes / Michel Rapinski, Alain Cuerrier -- Phytotherapeutics for cancer therapy / Daniel M.-Y. Sze, Hao Liu, Maureen V. Boost, Raimond Wong, Stephen Sagar -- Phytomedicines for fatty liver disease and functional gastrointestinal conditions / George Q. Li, Moon-Sun Kim, Fangming Jin, Jun-Lae Cho -- Phytomedicines for inflammatory conditions / Sigrun Chrubasik -- Phytotherapies for infectious diseases : are these really useful? / Gail B. Mahady, Gabrielle Escalante, Pooja Mikkilineni, Laura J. Mahady, Temitope O. Lawal, Bolanle A. Adeniyi -- Phytomedicines for CNS disorders : safe issues for use with anti-epileptic drugs? / Sophia Yui Kau Fong, Rosina Yau Mok, Qiong Gao, Yin Cheong Wong, Zhong Zuo -- Phytotherapy drug interactions in cancer / Andrew J. McLachlan, Stephen J. Clarke -- Quality use of medicines (QUM) considerations in phytotherapy / Lynn Weekes -- Intellectual property and patent issues with phytotherapy products / Gint Silin, Jennifer Tan, Kelvin Chan -- International regulatory status of phytotherapies / Ernest V. Linek. 330 $aVariously defined by its practitioners, phytotherapies include herbal therapies, treatments used by indigenous peoples around the world, and alternative medicines to classical western drugs. Despite an increasing trend toward the use of phytotherapies for chemoprevention and management of disease in healthcare, the published work about their efficacy and safety is scattered - and scientists need to understand these key issues along with regulatory aspects of phytotherpeutic agents. A number of herbs are likely to cause adverse effects if not properly standardized in clinical trials. Covering 606 $aMateria medica, Vegetable$vMethods 606 $aMateria medica, Vegetable$xStandards 615 0$aMateria medica, Vegetable 615 0$aMateria medica, Vegetable$xStandards. 676 $a615.321 702 $aRamzan$b Iqbal$f1951- 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910140489503321 996 $aPhytotherapies$91928739 997 $aUNINA